Lung cancer is one of the most common malignancies. Long-term smoking is a major cause of drug resistance and death in patients with lung cancer. Nicotine is the main component of cigarette smoke, and can affect the expressions of Bcl-2 family proteins in lung cancer cells, thereby promote the growth of cancer cells and enhance their drug resistance. This review aims to summarize the related studies on the relationships between nicotineenhanced drug resistance and Bcl-2 family proteins in lung cancer in recent years.